By Fineline Cube 
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its Armoni-HP peripheral high-pressure balloon dilatation catheter.
Product Profile
Armoni-HP is indicated for percutaneous transluminal angioplasty in peripheral vessels, including femoral, iliac, and renal arteries. It is also used for treating stenosis in native or synthetic dialysis arteriovenous fistulas and for post-stent dilation in peripheral vascular systems.
Technical Advantages
The product features a non-compliant balloon design made with ultra-high-strength fiber composite material, allowing it to withstand a maximum work pressure of up to 40 atm. This design facilitates effective dilation while potentially reducing the risk of vascular complications.
Commercial Strategy
Acotec plans to initiate commercial launch activities for the Armoni-HP in the Chinese market in the near future.-Fineline Info & Tech